Vraylar 1.5 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FC2S1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,450
Award facts
- Contract value 100% obligated
- $10,450.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Vraylar 1.5 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $10,450.27. This non-set-aside award was competitively procured and is set for completion by May 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery order from its corporate office location. Vraylar is a neurological medication used in federal military and healthcare supply chains, reflecting AmerisourceBergen's extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's track record of competitively awarded contracts and its position as a critical federal medical procurement vendor underscore its capability to fulfill specialized pharmaceutical requirements across the federal government's healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FC2S1?
SPE2DB25FC2S1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 12, 2025.
How much is contract SPE2DB25FC2S1 worth?
The government has obligated $10,450 on SPE2DB25FC2S1.
Is contract SPE2DB25FC2S1 an order under another contract?
Yes. SPE2DB25FC2S1 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FC2S1 competed?
The extent of competition for SPE2DB25FC2S1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award